Loveland, OH, United States of America

John E Coutant


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John E Coutant: Innovator in Bronchodilator Agents

Introduction

John E Coutant is a notable inventor based in Loveland, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as bronchodilator agents. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving respiratory health.

Latest Patents

Coutant holds a patent for a compound titled "6-Hydroxyalkylamino-8-methyl-1,2,4-triazolo-[4,3-b]pyridazine." This patent describes the synthesis of 8-Methyl-1,2,4-triazolo[4,3-b]pyridazines that possess a hydroxyalkylamino substituent at the 6-position. The compounds involved are particularly useful as bronchodilator agents and are prepared through the reaction of 6-chloro-8-methyl-1,2,4-triazolo[4,3-b]-pyridazine with an appropriate amino alcohol. This innovation highlights Coutant's commitment to advancing medical treatments.

Career Highlights

Coutant has had a distinguished career in the pharmaceutical industry. He is currently associated with Merrell Dow Pharmaceuticals, where he continues to contribute to the development of innovative medical solutions. His work has not only advanced scientific knowledge but has also had a positive impact on patient care.

Collaborations

Coutant has collaborated with various professionals in his field, including his coworker Robert J Cregge. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

John E Coutant is a prominent inventor whose work in the field of bronchodilator agents has made a significant impact on respiratory health. His patent and ongoing contributions to Merrell Dow Pharmaceuticals exemplify his dedication to innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…